Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

5.07
Delayed Data
As of 12:20pm ET
 +0.09 / +1.81%
Today’s Change
3.50
Today|||52-Week Range
13.00
-20.28%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close4.98
Today’s open5.26
Day’s range5.02 - 5.26
Volume14,210
Average volume (3 months)41,598
Market cap$379.8M
Dividend yield--
Data as of 12:20pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+34.08%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.07+0.60%
CFMSConforMIS Inc-0.24-2.96%
RTIXRTI Surgical Inc+0.05+1.54%
EYESSecond Sight Medical...-0.12-3.48%
Data as of 4:02pm ET, 08/25/2016

Financials

Last reporting dateAugust 25, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Partner Offers

Search for Jobs